Appointment booking for Dr. David Eschelbacher, MD is currently not available.Dr. David Eschelbacher, MD has not yet fully activated their profile on DiabetesIQ.
Dr. David Eschelbacher, MD (he/him) is a Internist in Tampa, FL with over 18 years of experience. What is your opinion of Dr. David Eschelbacher, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. David Eschelbacher, MD has received over $644 which includes payments from the following companies:
$155.92 from Astellas Pharma US Inc
$130.31 from Smith & Nephew, Inc.
$88.76 from Takeda Pharmaceuticals America, Inc.
$43.00 from Sunovion Pharmaceuticals Inc.
$36.76 from Novartis Pharmaceuticals Corporation
$25.51 from Boehringer Ingelheim Pharmaceuticals, Inc.
$22.70 from ACADIA Pharmaceuticals Inc
$17.34 from Radius Health, Inc.
$17.30 from Teva Pharmaceuticals USA, Inc.
$16.64 from Avanir Pharmaceuticals, Inc.
$15.52 from Purdue Pharma L.P.
$14.22 from LILLY USA, LLC
$13.92 from Novo Nordisk Inc
$13.42 from Mylan Specialty L.P.
$11.38 from E.R. Squibb & Sons, L.L.C.
$10.90 from Aprecia Pharmaceuticals Company
$10.69 from AstraZeneca Pharmaceuticals LP
Payments received by Dr. David Eschelbacher, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!